Feb 25, 2019
S-Network Appointed as Calculation Agent by Impax Asset Management for Impax Global Women's Leadership Index
Dec 03, 2018
Inline/ Instant Measurement for Pharma Extrusion – Impax
Oct 25, 2018
Expiration Dates for Certain Lots of Generic Adrenaclick® Epinephrine Injection, USP Auto-Injector Extended to 20 Months
Oct 24, 2018
Amneal Announces Issuance of New Patent for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa
Oct 19, 2018
Amneal Announces Approval of Carmustine for Injection USP, 100 mg/vial - Preparing for Launch
Sep 11, 2018
Global Primary Sclerosing Cholangitis Treatment Market 2018-2022: Key Vendors are Allergan, Glenmark, Impax Laboratories, Mylan & Teva Pharmaceuticals
Aug 31, 2018
Amneal Announces Partnership with American Regent on Generic Makena® and Progress on its Business Plan with Additional ANDA Approvals and Launches
Aug 20, 2018
Amneal Announces 10-Year Licensing and Supply Agreement with Jerome Stevens Pharmaceuticals, Inc. for Levothyroxine
Jul 23, 2018
Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution
Jun 29, 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray
Jun 20, 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary®
May 30, 2018
Amneal Announces FDA Approval of Cyclophosphamide for Injection USP, Generic to Cytoxan®
May 18, 2018
Amneal Pharmaceuticals Celebrates Combination by Ringing Opening Bell at New York Stock Exchange
May 17, 2018
Amneal Announces FDA Approval and Launch of Generic Welchol® (Colesevelam HCl) Tablets, 625 mg
May 15, 2018
Amneal Introduces First Generic for Mephyton® (Phytonadione) Tablets, 5mg
May 07, 2018
Amneal and Impax Complete Business Combination
Apr 27, 2018
Amneal And Impax Receive FTC Clearance For Business Combination
Mar 27, 2018
Impax Shareholders Approve Proposed Business Combination with Amneal
Mar 07, 2018
Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference
Feb 20, 2018
Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets